Biotechnological Advancements in Active Pharmaceutical Ingredient Removal: Sustainable Solutions for Pharmaceutical Wastewater Treatment

The increasing manufacture and use of medications has created a huge environmental challenge: water pollution with) These toxins endanger aquatic ecosystems and human health, necessitating the implementation of effective and long-term wastewater treatment technologies. Traditional treatment procedures, such as chemical oxidation and adsorption, frequently fail to remove APIs while emitting secondary contaminants entirely. Biotechnological breakthroughs have emerged as a possible alternative, enabling environmentally friendly and effective API elimination solutions. This study focuses on current advances in biotechnological techniques, such as enzymatic degradation, microbial bioreactors, and genetically modified microbes designed to remove API. The potential of improved biofilms and immobilized enzyme systems for improving the breakdown efficiency of resistant medicines is highlighted. Additionally, combining biotechnological technologies with conventional treatment procedures, such as membrane bioreactors (MBRs) and hybrid systems, is being investigated for synergistic results. Furthermore, this study underlines the importance of omics technologies, such as genomics, proteomics, and metabolomics, in understanding microbial pathways and improving bioprocesses for targeted API breakdown. Operational scalability, legal restrictions, and the environmental effect of biotechnology treatments are all addressed. This study seeks to educate academics, policymakers, and industry stakeholders on cutting-edge solutions that are consistent with environmental sustainability goals by giving a thorough overview of sustainable biotechnological technologies for API removal. The findings provided herein highlight biotechnology's potential to transform pharmaceutical wastewater treatment while reducing its environmental impact.